Published online November 5, 2007
doi:10.1084/jem.20062299
The Journal of Experimental Medicine, Vol. 204, No. 12, 2875-2888
The Rockefeller University Press, 0022-1007 $30.00
© 2007 Onoyama et al.
Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis
Ichiro Onoyama1,2,
Ryosuke Tsunematsu1,2,
Akinobu Matsumoto1,2,
Taichi Kimura3,
Ignacio Moreno de Alborán4,
Keiko Nakayama2,5, and
Keiichi I. Nakayama1,2
1 Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan
2 Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Kawaguchi, Saitama 332-0012, Japan
3 Laboratory of Molecular and Cellular Pathology, Hokkaido University Research Center for Zoonosis Control and 21st Century Center of Excellence Program for Zoonosis Control, Kita-ku, Sapporo 060-8638, Japan
4 Department of Immunology and Oncology, National Center for Biotechnology, Centro Nacional de Biotecnología, C/Darwin 3, 28049 Madrid, Spain
5 Department of Developmental Biology, Center for Translational and Advanced Animal Research, Graduate School of Medicine, Tohoku University, Aoba-ku, Sendai 980-8575, Japan
CORRESPONDENCE Keiichi I. Nakayama: nakayak1{at}bioreg.kyushu-u.ac.jp
Cell proliferation is strictly controlled during differentiation. In T cell development, the cell cycle is normally arrested at the CD4+CD8+ stage, but the mechanism underlying such differentiation-specific exit from the cell cycle has been unclear. Fbxw7 (also known as Fbw7, Sel-10, hCdc4, or hAgo), an F-box protein subunit of an SCF-type ubiquitin ligase complex, induces the degradation of positive regulators of the cell cycle, such as c-Myc, c-Jun, cyclin E, and Notch. FBXW7 is often mutated in a subset of human cancers. We have now achieved conditional inactivation of Fbxw7 in the T cell lineage of mice and found that the cell cycle is not arrested at the CD4+CD8+ stage in the homozygous mutant animals. The mutant mice manifested thymic hyperplasia as a result of c-Myc accumulation and eventually developed thymic lymphoma. In contrast, mature T cells of the mutant mice failed to proliferate in response to mitogenic stimulation and underwent apoptosis in association with accumulation of c-Myc and p53. These latter abnormalities were corrected by deletion of p53. Our results suggest that Fbxw7 regulates the cell cycle in a differentiation-dependent manner, with its loss resulting in c-Myc accumulation that leads to hyperproliferation in immature T cells but to p53-dependent cell-cycle arrest and apoptosis in mature T cells.
Abbreviations used: ARBP, acidic ribosomal phosphoprotein P0; DN, double negative; DP, double positive; ERK, extracellular signal-regulated kinase; ES, embryonic stem; JNK, c-Jun N-terminal kinase; mRNA, messenger RNA; SP, single positive.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Yokobori, T., Mimori, K., Iwatsuki, M., Ishii, H., Onoyama, I., Fukagawa, T., Kuwano, H., Nakayama, K. I., Mori, M.
(2009). p53-Altered FBXW7 Expression Determines Poor Prognosis in Gastric Cancer Cases. Cancer Res.
69: 3788-3794
[Abstract]
[Full Text]
-
Susaki, E., Nakayama, K., Yamasaki, L., Nakayama, K. I.
(2009). Common and specific roles of the related CDK inhibitors p27 and p57 revealed by a knock-in mouse model. Proc. Natl. Acad. Sci. USA
106: 5192-5197
[Abstract]
[Full Text]
-
Grim, J. E., Gustafson, M. P., Hirata, R. K., Hagar, A. C., Swanger, J., Welcker, M., Hwang, H. C., Ericsson, J., Russell, D. W., Clurman, B. E.
(2008). Isoform- and cell cycle-dependent substrate degradation by the Fbw7 ubiquitin ligase. JCB
181: 913-920
[Abstract]
[Full Text]
-
Minella, A. C., Loeb, K. R., Knecht, A., Welcker, M., Varnum-Finney, B. J., Bernstein, I. D., Roberts, J. M., Clurman, B. E.
(2008). Cyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages in vivo. Genes Dev.
22: 1677-1689
[Abstract]
[Full Text]
-
Thompson, B. J., Jankovic, V., Gao, J., Buonamici, S., Vest, A., Lee, J. M., Zavadil, J., Nimer, S. D., Aifantis, I.
(2008). Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7. JEM
205: 1395-1408
[Abstract]
[Full Text]
-
Matsuoka, S., Oike, Y., Onoyama, I., Iwama, A., Arai, F., Takubo, K., Mashimo, Y., Oguro, H., Nitta, E., Ito, K., Miyamoto, K., Yoshiwara, H., Hosokawa, K., Nakamura, Y., Gomei, Y., Iwasaki, H., Hayashi, Y., Matsuzaki, Y., Nakayama, K., Ikeda, Y., Hata, A., Chiba, S., Nakayama, K. I., Suda, T.
(2008). Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL. Genes Dev.
22: 986-991
[Abstract]
[Full Text]
-
Onoyama, I., Tsunematsu, R., Matsumoto, A., Kimura, T., de Alboran, I. M., Nakayama, K., Nakayama, K. I.
(2007). Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis. JCB
179: i7-i7
[Full Text]